Modulation of immune responses by immunotherapy in allergic diseases

Current Opinion in Pharmacology

Volumn 17, Issue 1, 2014, Pages 30-37

  Cavkaytar, Ozlem ^a,b,c   Akdis, Cezmi A ^a,c   Akdis, Mübeccel ^a,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Hochgebirgsklinik Children s Allergy and Asthma Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; OMALIZUMAB; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; ALLERGEN; BIOLOGICAL PRODUCT;

ALLERGEN IMMUNOTHERAPY; ALLERGIC DISEASE; CD4+ T LYMPHOCYTE; CELL COUNT; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; FOOD ALLERGY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PEANUT ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; TREATMENT DURATION; ANIMAL; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; PROCEDURES; TREATMENT OUTCOME;

ALLERGENS; ANIMALS; BIOLOGICAL PRODUCTS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME;

EID: 84905373691     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.07.003     Document Type: Review

References (60)

1. M. Akdis, and A.C. Akdis Immune tolerance B.S.B.N.F. Adkinson Jr. B.W. Busse, W.W. Holgate, S.T. Lemanske Jr. R.F. O'Hehir RE, Middleton's Allergy: Principle and Practice 2014 Elsevier Saunders Press 45 64
2. C. Mauri, and A. Bosma Immune regulatory function of B cells Annu Rev Immunol 30 2012 221 241
3. M. Akdis, and C.A. Akdis Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens J Allergy Clin Immunol 133 2014 621 631
4. W. van de Veen, B. Stanic, G. Yaman, M. Wawrzyniak, S. Sollner, D.G. Akdis, B. Ruckert, C.A. Akdis, and M. Akdis IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses J Allergy Clin Immunol 131 2013 1204 1212
5. A.W. Burks, M.A. Calderon, T. Casale, L. Cox, P. Demoly, M. Jutel, H. Nelson, and C.A. Akdis Update on allergy immunotherapy: American Academy of Allergy Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report J Allergy Clin Immunol 131 2013 1288 1296 e3
6. A. Syed, A. Kohli, and K.C. Nadeau Food allergy diagnosis and therapy: where are we now? Immunotherapy 5 2013 931 944
7. C.A. Akdis Therapies for allergic inflammation: refining strategies to induce tolerance Nat Med 18 2012 736 749
8. G. Senti, R. Crameri, D. Kuster, P. Johansen, J.M. Martinez-Gomez, N. Graf, M. Steiner, L.A. Hothorn, H. Grönlund, and C. Tivig et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections J Allergy Clin Immunol 129 2012 1290 1296
9. L. Jacobsen, B. Niggemann, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, A. Koivikko, L.A. Norberg, E. Valovirta, and U. Wahn et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948 (Pubitemid 47037870)
10. W. Lou, C. Wang, Y. Wang, D. Han, and L. Zhang Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children Pediatr Allergy Immunol 23 2012 140 149
11. A. Aslam, H. Chan, D.A. Warrell, S. Misbah, and G.S. Ogg Tracking antigen-specific T-cells during clinical tolerance induction in humans PLoS ONE 5 2010 e11028
12. A. Suarez-Fueyo, T. Ramos, A. Galan, L. Jimeno, P.A. Wurtzen, A. Marin, C. de Frutos, C. Blanco, A.C. Carrera, and D. Barber et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation J Allergy Clin Immunol 133 2014 130 138 e2
13. S.Z. Josefowicz, R.E. Niec, H.Y. Kim, P. Treuting, T. Chinen, Y. Zheng, D.T. Umetsu, and A.Y. Rudensky Extrathymically generated regulatory T cells control mucosal TH2 inflammation Nature 482 2012 395 399
14. S.Z. Josefowicz, L.F. Lu, and A.Y. Rudensky Regulatory T cells: mechanisms of differentiation and function Annu Rev Immunol 30 2012 531 564
15. M.A. Curotto de Lafaille, and J.J. Lafaille Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30 2009 626 635
16. C. Mobs, C. Slotosch, H. Loffler, T. Jakob, M. Hertl, and W. Pfutzner Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation J Immunol 184 2010 2194 2203
17. S. Radulovic, M.R. Jacobson, S.R. Durham, and K.T. Nouri-Aria Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa J Allergy Clin Immunol 121 2008 1467 1472 1472 e1
18. S.K. Lathrop, N.A. Santacruz, D. Pham, J. Luo, and C.S. Hsieh Antigen-specific peripheral shaping of the natural regulatory T cell population J Exp Med 205 2008 3105 3117
19. R.A. Gottschalk, E. Corse, and J.P. Allison TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo J Exp Med 207 2010 1701 1711
20. S.G. Zheng, J.H. Wang, W. Stohl, K.S. Kim, J.D. Gray, and D.A. Horwitz TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells J Immunol 176 2006 3321 3329 (Pubitemid 43363978)
21. H.S. McGee, H. Yagita, Z. Shao, and D.K. Agrawal Programmed death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma Am J Respir Cell Mol Biol 43 2010 432 442
22. M. Busse, M. Krech, A. Meyer-Bahlburg, C. Hennig, and G. Hansen ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance J Immunol 189 2012 1975 1982
23. M. Yadav, C. Louvet, D. Davini, J.M. Gardner, M. Martinez-Llordella, S. Bailey-Bucktrout, B.A. Anthony, F.M. Sverdrup, R. Head, and D.J. Kuster et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo J Exp Med 209 2012 1713 1722 S1-S19
24. A. Ephrem, A.L. Epstein, G.L. Stephens, A.M. Thornton, D. Glass, and E.M. Shevach Modulation of Treg cells/T effector function by GITR signaling is context-dependent Eur J Immunol 43 2013 2421 2429
25. W. Duan, T. So, and M. Croft Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells J Immunol 181 2008 8650 8659
26. J. Wisniewski, R. Agrawal, and J.A. Woodfolk Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts Clin Exp Allergy 43 2013 164 176
27. A. Saei, and J. Hadjati Tolerogenic dendritic cells: key regulators of peripheral tolerance in health and disease Int Arch Allergy Immunol 161 2013 293 303
28. X. Li, A. Yang, H. Huang, X. Zhang, J. Town, B. Davis, D.W. Cockcroft, and J.R. Gordon Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells Am J Respir Cell Mol Biol 42 2010 190 199
29. H. Huang, W. Dawicki, M. Lu, A. Nayyar, X. Zhang, and J.R. Gordon Regulatory dendritic cell expression of MHCII and IL-10 are jointly requisite for induction of tolerance in a murine model of OVA-asthma Allergy 68 2013 1126 1135
30. T. Ito, M. Yang, Y.H. Wang, R. Lande, J. Gregorio, O.A. Perng, X.F. Qin, Y.J. Liu, and M. Gilliet Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand J Exp Med 204 2007 105 115 (Pubitemid 46148761)
31. O. Palomares, B. Ruckert, T. Jartti, U.C. Kucuksezer, T. Puhakka, E. Gomez, H.B. Fahrner, A. Speiser, A. Jung, and W.W. Kwok et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance J Allergy Clin Immunol 129 2012 510 520 e1-9
32. A. Khare, N. Krishnamoorthy, T.B. Oriss, M. Fei, P. Ray, and A. Ray Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance J Immunol 191 2013 25 29
33. U.C. Kucuksezer, O. Palomares, B. Ruckert, T. Jartti, T. Puhakka, A. Nandy, B. Gemicioglu, H.B. Fahrner, A. Jung, and G. Deniz et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood J Allergy Clin Immunol 131 2013 875 885
34. G. Deniz, W. van de Veen, and M. Akdis Natural killer cells in patients with allergic diseases J Allergy Clin Immunol 132 2013 527 535
35. F. Meiler, J. Zumkehr, S. Klunker, B. Ruckert, C.A. Akdis, and M. Akdis In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure J Exp Med 205 2008 2887 2898
36. F. Fallarino, and U. Grohmann Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions Curr Med Chem 18 2011 2215 2221
37. C.A. Akdis, and M. Akdis Mechanisms of allergen-specific immunotherapy J Allergy Clin Immunol 127 2011 18 27 quiz 28-19
38. J.N. Francis, L.K. James, G. Paraskevopoulos, C. Wong, M.A. Calderon, S.R. Durham, and S.J. Till Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity J Allergy Clin Immunol 121 2008 1120 1125 e2
39. N. Novak, N. Mete, C. Bussmann, L. Maintz, T. Bieber, M. Akdis, J. Zumkehr, M. Jutel, and C. Akdis Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 J Allergy Clin Immunol 130 2012 1153 1158 e2
40. L. Maintz, C. Bussmann, T. Bieber, and N. Novak Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy J Allergy Clin Immunol 123 2009 701 703
41. M. Jutel, T. Watanabe, S. Klunker, M. Akdis, O.A. Thomet, J. Malolepszy, T. Zak-Nejmark, R. Koga, T. Kobayashi, and K. Blaser et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors Nature 413 2001 420 425 (Pubitemid 32928596)
42. L.K. James, H. Bowen, R.A. Calvert, T.S. Dodev, M.H. Shamji, A.J. Beavil, J.M. McDonnell, S.R. Durham, and H.J. Gould Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy J Allergy Clin Immunol 130 2012 663 670 e3
43. C. Mobs, H. Ipsen, L. Mayer, C. Slotosch, A. Petersen, P.A. Wurtzen, M. Hertl, and W. Pfutzner Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies J Allergy Clin Immunol 130 2012 1108 1116 e6
44. K.T. Nouri-Aria, P.A. Wachholz, J.N. Francis, M.R. Jacobson, S.M. Walker, L.K. Wilcock, S.Q. Staple, R.C. Aalberse, S.J. Till, and S.R. Durham Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity J Immunol 172 2004 3252 3259 (Pubitemid 38263717)
45. M. Akdis, S. Burgler, R. Crameri, T. Eiwegger, H. Fujita, E. Gomez, S. Klunker, N. Meyer, L. O'Mahony, and O. Palomares et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases J Allergy Clin Immunol 127 2011 701 721 e1-70
46. W. Lou, C. Wang, Y. Wang, D. Han, and L. Zhang Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy Int Arch Allergy Immunol 159 2012 391 398
47. L.K. James, M.H. Shamji, S.M. Walker, D.R. Wilson, P.A. Wachholz, J.N. Francis, M.R. Jacobson, I. Kimber, S.J. Till, and S.R. Durham Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies J Allergy Clin Immunol 127 2011 509 516 e1-5
48. A. Zaleska, T. Eiwegger, O. Soyer, W. van de Veen, C. Rhyner, M.B. Soyka, C. Bekpen, D. Demiröz, A. Treis, and S. Söllner et al. Immune regulation by intralymphatic immunotherapy with modular allergen-translocation MAT vaccine Allergy 2014 10.1111/all.12461
49. M.V. Kopp, E. Hamelmann, S. Zielen, W. Kamin, K.C. Bergmann, C. Sieder, S. Stenglein, S. Seyfried, U. Wahn, and Ds. group Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma Clin Exp Allergy 39 2009 271 279
50. M.V. Kopp, E. Hamelmann, M. Bendiks, S. Zielen, W. Kamin, K.C. Bergmann, C. Klein, U. Wahn, and Ds. group Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy Pediatr Allergy Immunol 24 2013 427 433
51. M. Massanari, H. Nelson, T. Casale, W. Busse, F. Kianifard, G.P. Geba, and R.K. Zeldin Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma J Allergy Clin Immunol 125 2010 383 389
52. L.C. Schneider, R. Rachid, J. LeBovidge, E. Blood, M. Mittal, and D.T. Umetsu A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients J Allergy Clin Immunol 132 2013 1368 1374
53. K.C. Nadeau, L.C. Schneider, L. Hoyte, I. Borras, and D.T. Umetsu Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy J Allergy Clin Immunol 127 2011 1622 1624
54. H.A. Sampson, D.Y. Leung, A.W. Burks, G. Lack, S.L. Bahna, S.M. Jones, and D.A. Wong A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy J Allergy Clin Immunol 127 2011 1309 1310 e1
55. C.A. Keet, P.A. Frischmeyer-Guerrerio, A. Thyagarajan, J.T. Schroeder, R.G. Hamilton, S. Boden, P. Steele, S. Driggers, A.W. Burks, and R.A. Wood The safety and efficacy of sublingual and oral immunotherapy for milk allergy J Allergy Clin Immunol 129 2012 448 455 e1-5
56. P. Varshney, S.M. Jones, A.M. Scurlock, T.T. Perry, A. Kemper, P. Steele, A. Hiegel, J. Kamilaris, S. Carlisle, and X. Yue et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response J Allergy Clin Immunol 127 2011 654 660
57. S.M. Jones, L. Pons, J.L. Roberts, A.M. Scurlock, T.T. Perry, M. Kulis, W.G. Shreffler, P. Steele, K.A. Henry, and M. Adair et al. Clinical efficacy and immune regulation with peanut oral immunotherapy J Allergy Clin Immunol 124 2009 292 300 e1-7
58. A. Syed, M.A. Garcia, S.C. Lyu, R. Bucayu, A. Kohli, S. Ishida, J.P. Berglund, M. Tsai, H. Maecker, and G. O'Riordan et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protin 3 (FOXP3) J Allergy Clin Immunol 133 2014 500 510
59. A. Rebane, and C.A. Akdis MicroRNAs: essential players in the regulation of inflammation J Allergy Clin Immunol 132 2013 15 26
60. M.B. Soyka, P. Wawrzyniak, T. Eiwegger, D. Holzmann, A. Treis, K. Wanke, J.I. Kast, and C.A. Akdis Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4 J Allergy Clin Immunol 130 2012 1087 1096 e10